EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy

Jianfeng Guo iD, Yifang Zou, Leaf Huang iD

Small Methods · 2023

DOI: 10.1002/smtd.202201307 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small Methods, 2023. Verfasst von Jianfeng Guo und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Jilin University, Changchun, 130021, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 89-mal zitiert (Crossref) und nennt 147 Literaturangaben. Gefördert von: Norman Bethune Program of Jilin University, China, Interdisciplinary Innovation Team of Norman Bethune Health Science Center of Jilin University, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunogenic cell death (ICD, also known as immunogenic apoptosis) of malignant cells is confirmed to activate the host immune system to prevent, control, and eliminate tumors. Recently, a range of chemotherapeutic drugs have been repurposed as ICD inducers and applied for tumor immunotherapy. However, several hurdles to the widespread application of chemotherapeutic ICD inducers remain, namely poor water solubility, short blood circulation, non‐specific tissue distribution, and severe toxicity. Recent advances in nanotechnology and pharmaceutical formulation foster the development of nano drug delivery systems to tackle the aforementioned hurdles and expedite safe, effective, and specific delivery. This review will describe delivery barriers to chemical ICD inducers and highlight recent nanoformulations for these drugs in tumor immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansCell DeathImmunotherapyApoptosis

Stichwörter der Autor:innen

cancer vaccinescombination therapydrug deliverynanoparticles

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Jilin University, Changchun, 130021, China.
  • Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, 27599, USA.

ORCID-Profile: Jianfeng Guo, Leaf Huang

Förderung

  • Norman Bethune Program of Jilin University, China
  • Interdisciplinary Innovation Team of Norman Bethune Health Science Center of Jilin University, China

Zitieren

APA

Guo, J., Zou, Y., & Huang, L. (2023). Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy. Small Methods. https://doi.org/10.1002/smtd.202201307

Vancouver

Guo J, Zou Y, Huang L. Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy. Small Methods. 2023. doi:10.1002/smtd.202201307

BibTeX
@article{Guo2023,
  author = {Guo, Jianfeng and Zou, Yifang and Huang, Leaf},
  title = {Nano Delivery of Chemotherapeutic ICD Inducers for Tumor Immunotherapy},
  journal = {Small Methods},
  year = {2023},
  doi = {10.1002/smtd.202201307}
}
Kostenlos starten →